KİTLE ŞEKLİNDE PREZENTE OLAN AMIODARONA BAĞLI BİR ORGANİZE PNÖMONİ OLGUSU
Amiodaron pulmoner fibrozise gidebilecek intertisyel pnömoniye neden olan antiaritmik bir ilaçtır. Altmış dört yaşında dispne, ateş, öksürük yakınması ile başvuran erkek hastanın özgeçmişinden amiodaron, metoprolol ve aspirin ilaçlarını kullandığı öğrenildi. Yüksek rezolüsyonlu bilgisayarlı tomografisinde (YRBT) bilateral üst loblarda lokalize konsolidasyon görünümlü lezyonların olması ve tru-cut doku biyopsisinin organize pnömoni olarak yorumlanması sonucunda hastada amiodarona bağlı pulmoner toksisite düşünüldü. Steroid tedavisi başlandıktan üç ay sonra çekilen göğüs radyogramında tam regresyon izlendi. Bu olguda YRBT'de amiodaron toksisitesinin en sık görülen bulgusu olan bilateral intertisyel infiltratlar yerine daha nadir görülen iyi lokalize edilen kitle ve konsolidasyon görünümlerin de olabileceği vurgulanmıştır. Ayrıca solunum sistemi yakınmaları ile gelen hastalarda öykü alırken kullanmakta olduğu ilaçları detaylı bir şekilde sorgulamakta yarar olduğunu düşünmekteyiz.
A CASE OF AMIODARONE INDUCED ORGANIZING PNEUMONIA PRESENTING AS A PULMONARY MASS
Amiodarone is an antiarrhythmic drug that can cause interstitial pneumonitis leading to pulmonary fibrosis. Amiodarone, metoprolol, and aspirin drugs had been used by a 64 year old man who admitted with dyspnea, fever, cough. Bilateral localized consolidation lesion was in upper lobes in high resolution computed tomography ( HRCT) and tru- cut tissue biyopsy was reported as organizing pneumonia; so amiodarone-induced pulmonary toxicity was thought in the patient. Three months after cessation of steroid treatment, chest radyogram shows complete regression of pneumonitis. The present case report demonstrates the localized mass, and consolidation lesions that is seen very rare instead of bilateral interstitial infiltrates that is the most common HRCT findings of amiodarone toxicity. In addition, we thougt that drugs that has been used must cross-examine in detail in the patients admitted with respiratory symptoms.
___
- 1. Marcus FI, Fontaine R, Grosgogeat Y. Clinical
pulmonary and therapeutic of the antiarrhythmic
agent, amiodarone. Am Heart J
1981; 101: 480-93.
- 2. Kennedy JI, Myers JL, Plumb VJ, Fulmer JD.
Amiodarone pulmonary toxicity. Arch Intern
Med 1987; 147: 50-5.
- 3. Sobol SM, Rakita L. Pneumonitis and pulmonary
fibrosis associated with amiodarone
treatment: A possible complication of a new
antiarrhythmic drug. Circulation 1982; 65:
819-24.
- 4. Piazza I, Bizzaro N. A localized pleuropulmonary
lesion induced by long-term therapy with
amiodarone. Respiration 1992; 59: 185-8.
- 5. Martin WJ, Rosenow EC. Amiodarone pulmonary
toxicity. Chest 1988; 93: 1245-8.
- 6. Dusman RE, Stanton MS, Miles WM, et al.
Clinical features of amiodarone-induced pulmonary
toxicity. Circulation 1980; 82: 51-9.
- 7. Martin WJ, Rosenow EC. Amiodarone pulmonary
toxicity: Recognition and pathogenesis.
Chest 1988; 93: 1067-75.
- 8. Vizioli LD, Cho S. Amiodarone-associated
hemoptysis. Chest 1994; 105: 305-6.
- 9. Camus P, Martin WJ II, Rosenow EC III.
Amiodarone pulmonary toxicity. Clin Chest
Med 2004; 25: 65-75.
- 10. Dean PJ, Groshart KD, Porterfield JG. Amiodarone
associated pulmonary toxicity. A
clinical and pathologic study of eleven
cases. Am J Clin Pathol 1987; 87: 7-13.
- 11. Jarand J, Lee A, Leigh R. Amiodaroma: An
unusual form of amiodarone-induced pulmonary
toxicity. CMAJ 2007; 176: 1411-3.
- 12. Azzam I, Tov N, Elias N, et al. Amiodarone
toxicity presenting as a pulmonary mass and
peripheral neuropathy: The continuing diagnostic
challenge. Postgrad Med J 2006; 82:
73-5.
- 13. Poll LW, May P, Koch JA, et al. HRCT findings
of amiodarone pulmonary toxicity: Clinical
and radiologic regression. J Cardiovasc
Pharmacol Ther 2001; 6: 307-11.
- 14. Shi JH, Liu HR, Zhu YJ, Xu WB. Clinicopathologic
manifestation of amiodarone-induced
lung injury. Zhonghua Bing Li Xue Za Zhi.
2006; 35: 394-7.
- 15. Dirlik A, Erinc R, Ozcan Z, et al. Technetium99m-DTPAaerosol
scintigraphy in amiodarone
induced pulmonary toxicity in comparison
with Ga-67 scintigraphy. Ann Nucl Med
2002; 16: 477-81.
- 16. Durmus-Altun G, Altun A, Aktas RG, et al.
Use of iodine-123 metaiodobenzylguanidine
scintigraphy for the detection of amiodarone
induced pulmonary toxicity in a rabbit model:
A comparative study with technetium- 99m
diethyltriaminepenta acetic acid radioaerosol
scintigraphy. Ann Nucl Med 2005; 19: 217-24.